Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.
Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 ...
Hims & Hers Health, Inc. HIMS trended on Wednesday after the company outlined an expanded weight-management push tied to ...
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe ...
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug ...
Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs. Federal regulators are seeking to rein in the online telemedicine platform ...
Novo Nordisk, maker of Wegovy, saw its stock rise 6.5% after the opening bell on Monday. The company and the U.S. Food and Drug Administration threatened legal action against Hims & Hers, over its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results